CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Sun Pharma entered into an agreement with AstraZeneca

Pritam Bhawar 0 3476 Article rating: 4.5

Sun Pharmaceutical Industries (Sun Pharma) announced that it has entered into a licensing agreement with AstraZeneca UK Ltd. (AstraZeneca) to introduce certain new ready to-use (RTU) infusion oncology products in China. These products will help in cancer treatments. The agreement will play a big role in bringing cost-effective and quality drugs to patients in China.

Q2 scorecard of Bandhan Bank

Pritam Bhawar 0 2442 Article rating: 5.0
Bandhan Bank on Thursday announced its result for second quarter. The Net Profit of the bank rose by 99.18 per cent to Rs. 972 crore against Rs 488 crore in same quarter previous year. However, the numbers for this quarter are not comparable to the same quarter last year due to its merger with Gruh Finance. 

U.S. FDA approved Lupin's Divalproex Sodium Extended-Release (ER) Tablets

Pritam Bhawar 0 2662 Article rating: 5.0

Lupin Limited received approval for its Divalproex Sodium Extended-Release (ER) Tablets USP, 250 mg and 500 mg, from the United States Food and Drug Administration (U.S. FDA), to market a generic equivalent of Depakote Extended-Release Tablets, 250 mg and 500 mg, of AbbVie Inc.

Religare Enterprises to conduct postal ballot for disinvestment

Pritam Bhawar 0 2674 Article rating: 5.0

Last week, Religare Enterprises announced that the company will conduct postal ballot to obtain approval of the shareholders of the company by the way of special resolution on disinvestment of entire investment of the company in material subsidiaries and Religare Housing Development Finance Corporation Limited and Sales, disposal and leasing of assets exceeding 20 per cent of assets of Religare Finvest Limited.

Maruti Suzuki drops after reducing prices by Rs. 5000

Pritam Bhawar 0 1554 Article rating: 5.0

Maruti Suzuki, India’s largest car maker on Wednesday announced reduction in prices of selected models by Rs. 5000. The price cut will be applicable on popular models including all variants of Alto 800, Alto K10, Swift Diesel, Celerio, Baleno Diesel, Ignis, Dzire Diesel, Tour S Diesel, Vitara Brezza and S-Cross.

Mindtree releases merchant on-boarding solution for banks

Pritam Bhawar 0 806 Article rating: 5.0

The technology services company, Mindtree, on Wednesday, announced the release of its ‘merchant on-boarding solution' for acquirer banks and payment service providers. In order to enable financial institutions with that facilitate credit card or debit payments to more quickly, seamlessly and securely onboard merchants as customer it uses hyperledger fabric blockchain technology.

JM Financials acquires debentures worth Rs.183.37 crore from JMFARC

Pritam Bhawar 0 1942 Article rating: 5.0

JM Financials on Thursday announced that the company has acquired 49,16,104 compulsorily convertible debentures (which are convertible into 4,91,61,040 equity shares as per the term of issue) of face value of Rs. 373 per share for cash aggregating Rs. 183.37 crore of JM Financial Asset Reconstruction Company Limited (JMFARC), a material subsidiary of the JM Financials.

Prabhat Dairy hits upper circuit on delisting plan

Pritam Bhawar 0 1739 Article rating: 4.5

Prabhat Dairy Limited on Friday informed that some of their promoters expressed their willingness to acquire 49.90 per cent of the paid-up equity shares capital that are presently held by public share holders. Cheering this news, shares of Prabhat Dairy surged 20 per cent to hit upper circuit limit at Rs. 78.15 on BSE.

Vascon wins Rs 465 crore tender

Pritam Bhawar 0 3471 Article rating: 3.5

Vascon Engineers Ltd. received an order worth Rs. 465 crore on September 4. The tender was offered by Maharashtra State Police Housing & Welfare Corporation (A Government of Maharashtra undertaking) for construction of staff quarters along with multipurpose hall in Mumbai.

Ashok Leyland becomes first OEM to meet BS-VI norms

Pritam Bhawar 0 6150 Article rating: 3.8

Ashok Leyland, a flagship company of the Hinduja group and country’s second largest commercial vehicle manufacturer, announced on Tuesday that, it has become the first Indian original equipment manufacturer to meet Bharat Stage VI emission norms across its full range of heavy duty trucks with gross vehicle weight of 16.2 tonnes and above.

Dilip Buildcon gains on completing Eeppurupalem project

Pritam Bhawar 0 3144 Article rating: 3.3

Dilip Buildcon Limited has received Provisional Completion Certificate for the project ‘ Rehabilitation and Upgradation of Eeppurupalem- ongole section from 195 km to 254.50 km/design ch. 184.910 km to 242.784 km of NH- 214A (New 216) to two lane with paved shoulder in the Andhra Pradesh State under NHDP-lV on EPC basis.

Wipro launches Digital Product Compliance lab in Hyderabad

Pritam Bhawar 0 2237 Article rating: 5.0

Wipro announced the launch of a global Digital Product Compliance lab in Hyderabad, on Tuesday. The new lab has a key focus on security and is equipped with cutting-edge environment chambers designed to simulate harsh environments to test products. It also features a state-of-the-art facility for Wi-Fi devices.

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR